What are the potential risks and benefits of administering low molecular weight heparin for thromboprophylaxis in cancer patients during hospitalization?
Low molecular weight heparin is effective for thromboprophylaxis in hospitalized cancer patients, significantly reducing VTE incidence. It has a favorable risk profile, though monitoring for bleeding and HIT is essential.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.5281/zenodo.24322893
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00